Fighting falsified medicines: The analytical approach

•Overview of the falsification of medicinal products.•Inventory of analytical methods with state-of-the-art techniques and portable devices.•Proposition of a methodology combining analytical methods.•Illustration of the analytical methodology with examples from the literature.•Focus on 3 groups of d...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of pharmaceutical and biomedical analysis 2017-08, Vol.142, p.286-306
Hauptverfasser: Rebiere, Hervé, Guinot, Pauline, Chauvey, Denis, Brenier, Charlotte
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:•Overview of the falsification of medicinal products.•Inventory of analytical methods with state-of-the-art techniques and portable devices.•Proposition of a methodology combining analytical methods.•Illustration of the analytical methodology with examples from the literature.•Focus on 3 groups of drugs: erectile dysfunction, weight loss and antimalarial. Given the harm to human health, the fight against falsified medicines has become a priority issue that involves numerous actors. Analytical laboratories contribute by performing analyses to chemically characterise falsified samples and assess their hazards for patients. A wide range of techniques can be used to obtain individual information on the organic and inorganic composition, the presence of an active substance or impurities, or the crystalline arrangement of the formulation’s compound. After a presentation of these individual techniques, this review puts forward a methodology to combine them. In order to illustrate this approach, examples from the scientific literature (products used for erectile dysfunction treatment, weight loss and malaria) are placed in the centre of the proposed methodology. Combining analytical techniques allows the analyst to conclude on the falsification of a sample, on its compliance in terms of pharmaceutical quality and finally on the safety for patients.
ISSN:0731-7085
1873-264X
DOI:10.1016/j.jpba.2017.05.010